Dr. Wagner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1800 Orleans St.,Sheikh Zayed Tower
Baltimore, MD 21287Phone+1 443-923-9525Fax+1 443-923-9405- Is this information wrong?
Education & Training
- Johns Hopkins UniversityFellowship, Clinical Neurophysiology, 1998 - 1999
- Johns Hopkins UniversityResidency, Neurology, 1995 - 1998
- Johns Hopkins UniversityResidency, Internal Medicine, 1994 - 1995
- Johns Hopkins University School of MedicineClass of 1994
Certifications & Licensure
- MD State Medical License 1998 - 2025
- American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Revatio for Heart Disease in Duchenne Muscular Dystrophy and Becker Muscular Dystrophy Start of enrollment: 2010 Sep 01
- Finding the Optimum Regimen for Duchenne Muscular Dystrophy Start of enrollment: 2013 Jan 01
- Magnetic Resonance Imaging and Spectroscopy Biomarkers for Facioscapulohumeral Muscular Dystrophy Start of enrollment: 2012 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsQuantitative muscle analysis in facioscapulohumeral muscular dystrophy using whole-body fat-referenced MRI: Protocol development, multicenter feasibility, and repeatab...Per Widholm, André Ahlgren, Markus Karlsson, Thobias Romu, Rabi Tawil, Kathryn R Wagner, Jeffrey M Statland, Leo H Wang, Perry B Shieh, Baziel G M van Engelen, Diego C...> ;Muscle & Nerve. 2022 Aug 1
- 7 citationsQuantitative magnetic resonance imaging measures as biomarkers of disease progression in boys with Duchenne muscular dystrophy: a phase 2 trial of domagrozumab.Sarah P Sherlock, Jeffrey Palmer, Kathryn R Wagner, Hoda Z Abdel-Hamid, Enrico Bertini, Cuixia Tian, Jean K Mah, Anna Kostera-Pruszczyk, Francesco Muntoni, Michela Gug...> ;Journal of Neurology. 2022 Aug 1
- 8 citationsRandomized phase 2 study of ACE-083, a muscle-promoting agent, in facioscapulohumeral muscular dystrophy.Jeffrey M Statland, Craig Campbell, Urvi Desai, Chafic Karam, Jordi Díaz-Manera, Jeffrey T Guptill, Lawrence Korngut, Angela Genge, Rabi N Tawil, Lauren Elman, Nanette...> ;Muscle & Nerve. 2022 Jul 1
- Join now to see all
Press Mentions
- Longitudinal Functional and Imaging Outcome Measures in FKRP Limb-Girdle Muscular DystrophyMay 19th, 2020
- Catabasis Pharmaceuticals Provides Update on Global Phase 3 PolarisDMD Trial for Edasalonexent at Parent Project Muscular Dystrophy 25th Annual ConferenceJune 27th, 2019
Professional Memberships
- Member
Hospital Affiliations
- Kennedy Krieger InstituteBaltimore, Maryland
External Links
- Wagner labhttps://www.thewagnerlab.org/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: